Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice

Journal of Lipid Research

Volumn 40, Issue 5, 1999, Pages 893-900

  Marsh, Marion M ^a   Walker, V Robert ^a   Curtiss, Linda K ^a   Banka, Carole L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Cervical carcinoma; Cholesterol; Estradiol; Estrogen; Hormone replacement therapy; LDL receptor deficient mice; Mouse model; Triglyceride

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTROGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; PLACEBO; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HORMONE SUBSTITUTION; MENOPAUSE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOMATOLOGY;

EID: 0032945571     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-2275(20)32124-6     Document Type: Article

References (31)

1. Bush, T. L., L. P. Fried, and E. Barrett-Connor. 1988. Cholesterol, lipoproteins, and coronary heart disease in women. Clin. Chem. 34: B60-B70.
2. Stampfer, M. J., and G. A. Colditz. 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20: 47-63.
3. Grady, D., S. M. Rubin, D. B. Petitti, C. S. Fox, D. Black, B. Ettinger, V. L. Ernster, and S. R. Cummings. 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117: 1016-1037.
4. Farhat, M. Y., M. C. Lavigne, and P. W. Ramwell. 1996. The vascular protective effects of estrogen. FASEB J. 10: 615-624.
5. Bourassa, P. A., P. M. Milos, B. J. Gaynor, J. L. Breslow, and R. J. Aiello. 1996. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA. 93: 10022-10027.
6. Elhage, R., J. F. Arnal, M. T. Pieraggi, N. Duverger, C. Fievet, J. C. Faye, and F. Bayard. 1997. 17 β-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 17: 2679-2684.
7. Ishibashi, S., J. L. Goldstein, M. S. Brown, J. Herz, and D. K. Burns. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93: 1885-1893.
8. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328.
9. Palinski, W., V. A. Ord, A. S. Plump, J. L. Breslow, D. Steinberg, and J. L. Witztum. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14: 605-616.
10. Boisvert, W. A., J. Spangenberg, and L. K. Curtiss. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96: 1118-1124.
11. Gamble, W., M. Vaughan, H. S. Kruth, and J. Avigan. 1978. Procedure for determination of free and total cholesterol in micro-or nanogram amounts suitable for studies with cultured cells. J. Lipid Res. 19: 1068-1070.
12. Anstead, G. M., K. E. Carlson, and J. A. Katzenellenbogen. 1997. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids. 62: 268-303.
13. Kuiper, G. G., E. Enmark, M. Pelto-Huikko, S. Nilsson, and J. A. Gustafsson. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA. 93: 5925-5930.
14. Leygue, E., H. Dotzlaw, B. Lu, C. Glor, P. H. Watson, and L. C. Murphy. 1998. Estrogen receptor beta: mine is longer than yours? J. Clin. Endocrinol. Metab. 83: 3754-3755.
15. Sullivan, T. R., Jr., R. H. Karas, M. Aronovitz, G. T. Faller, J. P. Ziar, J. J. Smith, T. F. O'Donnell, Jr., and M. E. Mendelsohn. 1995. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96: 2482-2488.
16. Iafrati, M. D., R. H. Karas, M. Aronovitz, S. Kim, T. R. Sullivan, Jr., D. B. Lubahn, T. F. O'Donnell, Jr., K. S. Korach, and M. E. Mendelsohn. 1997. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3: 545-548.
17. Gambacciani, M., M. Ciaponi, B. Cappagli, L. Piaggesi, L. De Simone, and A. R. Genazzani. 1997. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J. Clin. Endocrinol. Metab. 82: 414-417.
18. Wagner, J. D., M. A. Martino, M. J. Jayo, M. S. Anthony, T. B. Clarkson, and W. T. Cefalu. 1996. The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metabolism. 45: 1254-1262.
19. Wade, G. N. and J. M. Gray. 1979. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol. Behav. 22: 583-593.
20. Cauley, J. A., J. P. Gutai, L. H. Kuller, and J. G. Powell. 1991. Reliability and interrelations among serum sex hormones in postmenopausal women. Am. J. Epidemiol. 133: 50-57.
21. Korach, K. S. 1979. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems. Endocrinology. 104: 1324-1332.
22. Quarmby, V. E., C. Fox-Davies, M. H. Swaisgood, and K. S. Korach. 1982. Estrogen action in the mouse uterus: adrenal modulation of receptor levels. Endocrinology. 110: 1208-1216.
23. Drill, V. A. 1976. Effect of estrogens and progestins on the cervix uteri. J. Toxicol. Environ. Health. Suppl. 1: 193-204.
24. Gardner, W. U., and E. Allen. 1939, Malignant and non-malignant uterine and vaginal lesions in mice receiving estrogens and androgens simultaneously. Yale J. Biol. Med. 12: 213-240.
25. Allen, E., and W. U. Gardner. 1941. Cancer of the cervix of the uterus in hybrid mice following long-continued administration of estrogen. Cancer Res. 1: 359-366.
26. Newnham, H. H. 1993. Oestrogens and atherosclerotic vascular disease-lipid factors. Baillieres Clin. Endocrinol. Metab. 1: 61-93.
27. Ma, P. T., T. Yamamoto, J. L. Goldstein, and M. S. Brown. 1986. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17α-ethinyl estradiol. Proc. Natl. Acad. Sci. USA. 83: 792-796.
28. Henriksson, P., M. Stamberger, M. Eriksson, M. Rudling, U. Diczfalusy, L. Berglund, and B. Angelin. 1989. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur. J. Clin. Invest. 19: 395-403.
29. Srivastava, R. A., N. Srivastava, M. Averna, R. C. Lin, K. S. Korach, D. B. Lubahn, and G. Schonfeld. 1997. Estrogen up-regulates apolipoprotein E (apoE) gene expression by increasing apoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J. Biol. Chem. 272: 33360-33366.
30. Olsen, N. J., and W. J. Kovacs. 1996. Gonadal steroids and immunity. Endocr. Rev. 17: 369-384.
31. Banka, C. L. 1998. Non-genomic actions of estrogens: estrogens as antioxidants. In Estrogen and the Vessel Wall. G. Rubanyi, editor. Harwood Academic Publishers, Newark, NJ. 91-106.